5th International HIPS-Symposium

HIPS Symposium 2014

The HIPS-Symposium brings together renowned scientists and young investigators from three pharmaceutical communities: natural products, medicinal chemistry and drug delivery. It provides a forum for senior scientists to exchange ideas while crossing borders of classical disciplines. At the same time it gives young investigators the chance to get valuable feedback on their projects by international experts in the respective fields.

  • Overview

    The HIPS-Symposium will take place in the Aula (bldg. A3.3) on campus of Saarland University. Meals, snacks and drinks will be provided. The participation is free of charge.

    Posters of young scientists are especially welcome. The poster boards at the conference venue are suited for posters in the format DIN A0 (upright).

    Registration is required for each participant via the online form. Deadline for registration and poster abstract submission is May 6, 2015.  

     

    To get to the website of HIPS please click here


    Date: 02.07.2015, 09:00

    Location

    Campus of Saarland University

    Building and room

    Aula (Gebäude A3.3)

    Speaker

    Stefaan De Smedt, Ghent University, Belgium

    Exploring nano- and micromaterials to combat infectious diseases: about our failures and successes    

     

    Elias Fattal, University of Paris Sud IX, France

    CD44 targeted nanotechnologies    

     

    Wolf-Dietrich Hardt, ETH Zürich, Switzerland

    Salmonella diarrhea: which pathogen-microbiota-host interactions may offer targets for therapy?”    

     

    Anthony Hickey, RTI International, USA

    Dry Powder Aerosols for Tuberculosis Treatment     

     

    Ulrike Holzgrabe, University of Würzburg, Germany

    Small Molecule for Treatment of Critical Infectious Diseases

     

    Scott Hultgren, Washington University in St. Louis, USA

    Molecular Blueprint of Uropathogenic E. coli Pathogenesis and Targeted Therapies    

     

    Laurence Rahme, Harvard Medical School, USA

    Anti-Virulence Therapies against Acute and Relapsing Pseudomonas aeruginosa Infections    

     

    Barrie Wilkinson, John Innes Center, UK

    Bioengineering for natural product lead optimization    

     

    Daniel Wilson, Ludwig-Maximilians-Universität Munich, Germany

    Man against Microbe: Ribosome-targeting Antibiotics and Resistance Mechanisms

  • Programme

    Thursday, July 2, 2015

    Saarland University, Campus, Building A3 3 (Aula), D-66123 Saarbrücken

     

    09:00 - 09:40    

    Welcome

    Rolf Müller, Managing Director of HIPS

    Susanne Reichrath, State Chancellory of Saarland

    Volker Linneweber, President of Saarland University

    Dirk Heinz, Scientific Director of HZI

     

    Presentation Session I

    Chair: Rolf Müller, Managing Director of HIPS and Head of HIPS-Department Microbial Natural Products

     

    09:40 - 10:10    

    Barrie Wilkinson, John Innes Center, UK

    Bioengineering for natural product lead optimization

     

    10:10 – 10:40    

    Daniel Wilson, Ludwig-Maximilians-Universität Munich, Germany

    Man against Microbe: Ribosome-targeting Antibiotics and Resistance Mechanisms

     

    10:40 – 11:10             

    Wolf-Dietrich Hardt, ETH Zürich, Switzerland

    Salmonella diarrhea: which pathogen-microbiota-host interactions may offer targets for therapy?

     

    11:10 - 11:45

    Coffee Break - Poster Session I

     

     

    Presentation Session II

    Chair: Rolf W. Hartmann, Head of HIPS-Department Drug Design and Optimization

     

    11:45 - 12:15              

    Laurence Rahme, Harvard Medical School, USA

    Anti-Virulence Therapies against Acute and Relapsing Pseudomonas aeruginosa Infections

     

    12:15 – 12:45            

    Scott Hultgren, Washington University in St. Louis, USA

    Molecular Blueprint of Uropathogenic E. coli Pathogenesis and Targeted Therapies

     

    12:45 – 13:15             

    Ulrike Holzgrabe, University of Würzburg, Germany

    Small Molecule for Treatment of Critical Infectious Diseases

     

    13:15 - 14:30  

    Lunch - Poster Session II

     

     

    Presentation Session III

    Chair: Wilhelm Boland, Head of Department Bioorganic Chemistry, Max Planck Institute for Chemical Ecology, Jena, Germany, and President of the Scientific Advisory Board of HIPS

     

    14:30 – 15:45             

    HIPS Podium

     

    Angela KIing, Department of Microbial Natural Products

    Griselimycins: novel antituberculosis leads that target the sliding clamp

     

    Martin Empting, Department of Drug Design and Optimization

    Targeting Biosynthesis of the Pseudomonas Quinolone Signal: Promises and Premises for Quorum Sensing Inhibitors

     

    Maike Windbergs, Department of Drug Delivery

    Combating wound infections – strategies for drug delivery and analytics

     

    Stefanie Wagner, Junior Research Group: Chemical Biology of Carbohydrates

    Characterization of the lectin LecB from the highly virulent strain Pseudomonas aeruginosa PA14

     

    Maksym Myronovski, Junior Research Group: Actinobacteria Metabolic Engineering

    Gaining access to biosynthetic potential of actinobacteria

     

    Jesko Köhnke, Junior Research Group: Stuctural Biology of Biosynthetic Enzymes

    Structural insights into RiPPs biosynthesis

     

    15:45 – 16:10             

    EuroPhD Awards

     

    Tadeja Lukezic (MINS)

    Chelocardin biosynthetic gene cluster as a platform for construction of a new

    class of tetracycline lead structures

     

    Michael Storz (DDOP)

    Effects of pqs modulators on the quorum sensing circuit of Pseudomonas aeruginosa

     

    Birgit Teubl (DDEL)

    Interactions of Nanostructured Materials with the Oral Cavity

     

    16:10 - 16:30             

    Poster Session III - Coffee Break

     

     

    Presentation Session IV

     

    Chair: Claus-Michael Lehr

    Head of HIPS-Department Drug Delivery

     

    16:30 – 17:00             

    Anthony Hickey, RTI International, USA

    Dry Powder Aerosols for Tuberculosis Treatment

     

    17:00 - 17:30              

    Elias Fattal, University of Paris Sud IX, France

    CD44 targeted nanotechnologies

     

    17:30 – 18:00             

    Stefaan De Smedt, Ghent University, Belgium

    Exploring nano- and micromaterials to combat infectious diseases: about our failures and successes

     

    18:00

    Barbecue

  • Register

  • Directions

    How to find us in Saarbrücken 

    The HIPS building is located at the east entrance on the main campus of Saarland University, which is situated outside the city centre of Saarbrücken, the state capital of Saarland. Saarland is located in the south-west of Germany, having common frontiers with Luxembourg and France.

    Address

    Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS)
    Universitätscampus E8 1
    66123 Saarbrücken
    Germany

    By car

    • from the north (Cologne/Trier) via the motorway A1/A8 to „Autobahnkreuz Neunkirchen“, take A6 to „Saarbrücken“
    • from the east (Kaiserslautern/Mannheim) via A6 to "Saarbrücken/Paris"
    • from the north-west from Luxembourg via A620 by-pass the city centre and follow A6 to „Mannheim“
    • from the west (Metz/Paris) and south-west (Strasbourg) via the A4/A320 (E50) follow A6 (E50) to „Mannheim“
    • to reach the campus from motorway A6: take exit no. 5 „St. Ingbert West/Universität“, follow „Universität Ost“, (ca. 6 km)

    By train

    (ICE/TGV and Intercity - Saarbrücken Central Station) you can reach the campus by local busses from the main train station (112, 124) and the city centre (101, 102, 109, 111) within 15 min 
    (see www.bahn.de)


    Downloads

Contact

  • Birgitta Lelarge

    Birgitta Lelarge

    Assistant to the director

    +49 681 98806-3022

    +49 681 98806-3003

    Contact

Downloads

HIPS SYMP-Bild 2015

Flyer

Abstract Template

Involved Groups